Ionis Pharmaceuticals IONS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $246.09M+21.0% | $203.33M+29.7% | $156.72M-65.3% | $452.05M+243% | $131.61M-41.9% | ||
| $2.98M-62.5% | $7.96M+240% | $2.34M-43.7% | $4.15M+184% | $1.46M-61.8% | ||
| $243.11M+24.4% | $195.37M+26.6% | $154.38M-65.5% | $447.9M+244% | $130.15M-41.6% | ||
| 98.8%+2.7pp | 96.1%-2.4pp | 98.5%-0.6pp | 99.1%+0.2pp | 98.9%+0.6pp | ||
| —— | $228.9M0.0% | $228.9M0.0% | $228.9M0.0% | $228.9M+1.6% | ||
| $150.36M+15.5% | $130.19M+34.5% | $96.81M+6.8% | $90.62M+18.8% | $76.25M-13.4% | ||
| $363.52M-13.0% | $417.79M+31.8% | $316.9M+1.5% | $312.23M+12.1% | $278.47M-17.5% | ||
| -$117.42M+45.2% | -$214.46M-33.9% | -$160.18M-215% | $139.82M+195% | -$146.86M-32.5% | ||
| -47.7%+57.8pp | -105.5%-3.3pp | -102.2%-133pp | 30.9%+143pp | -111.6%-62.7pp | ||
| $5.16M+6.9% | $4.83M+14.6% | $4.21M+2.4% | $4.11M+0.1% | $4.11M-2.0% | ||
| -$456K+97.2% | -$16.29M-4,587% | $363K+256% | $102K-78.1% | $465K+54.0% | ||
| -$92.31M+59.5% | -$227.92M-77.5% | -$128.39M-204% | $123.53M+184% | -$146.82M-37.2% | ||
| $218K-85.3% | $1.48M+594% | $213K+1,165% | -$20K-117% | $116K+104% | ||
| -$92.53M+59.7% | -$229.39M-78.4% | -$128.61M-204% | $123.55M+184% | -$146.94M-40.8% | ||
| -37.6%+75.2pp | -112.8%-30.8pp | -82.1%-109pp | 27.3%+139pp | -111.6%-65.6pp | ||
| -$0.56+60.3% | -$1.41-76.2% | -$0.80-214% | $0.70+175% | -$0.93-40.9% | ||
| -$113.46M+46.1% | -$210.56M-33.9% | -$157.31M-210% | $142.68M+199% | -$144.05M-33.2% | ||
| -46.1%+57.5pp | -103.6%-3.2pp | -100.4%-132pp | 31.6%+141pp | -109.5%-61.7pp | ||
| -$117.42M+45.2% | -$214.46M-33.9% | -$160.18M-215% | $139.82M+195% | -$146.86M-32.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ionis Pharmaceuticals's revenue?
- Ionis Pharmaceuticals (IONS) generated $1.1B in revenue over the trailing twelve months, up 47.5% year over year.
- Is Ionis Pharmaceuticals profitable?
- Ionis Pharmaceuticals is not currently profitable: it reported a net loss of $327.0M over the trailing twelve months, a -30.9% net margin.
- What are Ionis Pharmaceuticals's profit margins?
- Gross margin is 98.4% and operating margin is -33.3%, with a -30.9% net margin.
- What is Ionis Pharmaceuticals's earnings per share?
- Ionis Pharmaceuticals's diluted EPS over the trailing twelve months is $-2.07.
- Where does Ionis Pharmaceuticals's income statement data come from?
- Every line is extracted from Ionis Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
